| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |